Global Health Clinics Ltd. (CSE:MJRX.X)
Canada · Delayed Price · Currency is CAD 0.0550
0.00 (0.00%)
Aug 24, 2026, 9:41 AM EST
Global Health Clinics Balance Sheet
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Cash & Equivalents | 0.03 | 0.05 | 0.01 | 0.21 | 0.5 | 0.46 |
Cash & Short-Term Investments | 0.03 | 0.05 | 0.01 | 0.21 | 0.5 | 0.46 |
Cash Growth | 556.58% | 449.29% | -95.71% | -56.85% | 8.86% | 407.75% |
Accounts Receivable | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
Other Receivables | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 |
Receivables | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 |
Prepaid Expenses | 0 | - | - | 0.01 | 0.04 | 0.11 |
Other Current Assets | - | - | - | - | 0.01 | 0.01 |
Total Current Assets | 0.04 | 0.07 | 0.03 | 0.24 | 0.58 | 0.61 |
Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 |
Other Intangible Assets | 0 | - | - | - | - | - |
Total Assets | 0.04 | 0.07 | 0.03 | 0.24 | 0.58 | 0.61 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Accounts Payable | 0.95 | 0.86 | 0.77 | 0.69 | 0.55 | 0.74 |
Accrued Expenses | 0.64 | 0.55 | 0.38 | 0.21 | 0.04 | 0.13 |
Short-Term Debt | 2.98 | 2.34 | 1.52 | 0.79 | 0.29 | 0.03 |
Current Unearned Revenue | 0.01 | 0 | 0.02 | 0.02 | 0.03 | 0.04 |
Other Current Liabilities | 1 | 0.83 | 0.6 | 0.4 | 0.19 | 0.1 |
Total Current Liabilities | 5.57 | 4.59 | 3.29 | 2.12 | 1.1 | 1.05 |
Long-Term Debt | - | - | - | 0.31 | 0.03 | - |
Total Liabilities | 5.57 | 4.59 | 3.29 | 2.43 | 1.14 | 1.05 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Common Stock | 26.24 | 26.24 | 26.24 | 26.24 | 26.24 | 25.6 |
Additional Paid-In Capital | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Retained Earnings | -38.7 | -37.7 | -36.44 | -35.36 | -33.73 | -32.36 |
Comprehensive Income & Other | 6.81 | 6.81 | 6.81 | 6.81 | 6.81 | 6.19 |
Total Common Equity | -5.63 | -4.63 | -3.36 | -2.28 | -0.66 | -0.54 |
Shareholders' Equity | -5.53 | -4.53 | -3.26 | -2.18 | -0.56 | -0.44 |
Total Liabilities & Equity | 0.04 | 0.07 | 0.03 | 0.24 | 0.58 | 0.61 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Total Debt | 2.98 | 2.34 | 1.52 | 1.1 | 0.32 | 0.03 |
Net Cash (Debt) | -2.95 | -2.29 | -1.51 | -0.89 | 0.17 | 0.43 |
Net Cash Growth | - | - | - | - | -59.01% | 581.73% |
Net Cash Per Share | -2.82 | -2.20 | -1.45 | -0.85 | 0.42 | 1.81 |
Filing Date Shares Outstanding | 1.04 | 1.04 | 1.04 | 1.04 | 1.04 | 0.43 |
Total Common Shares Outstanding | 1.04 | 1.04 | 1.04 | 1.04 | 1.04 | 0.34 |
Working Capital | -5.53 | -4.53 | -3.26 | -1.88 | -0.53 | -0.44 |
Book Value Per Share | -5.39 | -4.44 | -3.22 | -2.19 | -0.63 | -1.58 |
Tangible Book Value | -5.63 | -4.63 | -3.36 | -2.28 | -0.66 | -0.54 |
Tangible Book Value Per Share | -5.39 | -4.44 | -3.22 | -2.19 | -0.63 | -1.58 |
Machinery | 0.01 | 0.01 | 0.01 | - | - | - |